The Buddhasothorn Asthma Severity Score (BASS): A practical screening tool for predicting severe asthma exacerbations for pediatric patients
Allergologia et Immunopathologia · 2023
DOI: 10.15586/aei.v51i2.690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2023. Verfasst von Suttipong Ittiporn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Pediatrics, Buddhasothorn Hospital, Chachoengsao, Thailand; suttipong.itt@gmail.com. Hauptthemen laut MEDLINE: Bronchodilator Agents, Asthma. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and aim: A precise scaling system of acute asthma leads to an accurate assessment of disease severity. This study aimed to compare the accuracy of the Buddhasothorn Asthma Severity Score (BASS) with the Wood–Downes–Ferrés Scale (WDFS) to recognize the severity level of acute asthma. Materials and methods: A cross-sectional study was conducted comprising Thai children aged 2–15 years with acute asthma. The BASS and WFDS were rated once in the emergency department. The degree of severity was determined by frequency and type of nebulized bronchodilator administrations at the time of initial treatment. The optimum cutoff points for the area under the curve (AUC) were established to predict severe asthma exacerbations.
Results
All 73 episodes of asthma exacerbations (EAEs) in 35 participants were analyzed. Fifty-nine (80.8%) EAEs were classified as severe. Both scales had good significance to recognize the selection of nebulized bronchodilator treatments by AUC of 0.815 (95% Confidence Interval [CI]: 0.680–0.950) in case of BASS, and AUC of 0.822 (95% CI: 0.70–0.944) in case of WDFS. Cutoff points of BASS ≥ 8 had sensitivity 72.9%, specificity 64.3%, positive predictive value (PPV) 89.6%, negative predictive value (NPV) 36.0% at an AUC of 0.718 (95% CI: 0.563–0.873) for severe exacerbations. These results were consistent for cutoff points of WDFS ≥ 5 with sensitivity 78.0%, specificity 50.0%, PPV 86.8%, NPV 35.0% at an AUC of 0.768 (95% CI: 0.650–0.886) for predicting severe exacerbations. There was no significant difference between the AUCs of both scales.
Conclusions
Both the BASS and WDFS were good and accurate scales and effective screening tools for predicting severe asthma exacerbations in pediatric patients by optimal cutoff points.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Department of Pediatrics, Buddhasothorn Hospital, Chachoengsao, Thailand; suttipong.itt@gmail.com.
- Division of Nursing Services, Department of Pediatrics, Buddhasothorn Hospital, Chachoengsao, Thailand.
Zitieren
APA
Ittiporn, S., & Prajongdee, K. (2023). The Buddhasothorn Asthma Severity Score (BASS): A practical screening tool for predicting severe asthma exacerbations for pediatric patients. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v51i2.690
Vancouver
Ittiporn S, Prajongdee K. The Buddhasothorn Asthma Severity Score (BASS): A practical screening tool for predicting severe asthma exacerbations for pediatric patients. Allergologia et Immunopathologia. 2023. doi:10.15586/aei.v51i2.690
BibTeX
@article{Ittiporn2023,
author = {Ittiporn, Suttipong and Prajongdee, Kanlaya},
title = {The Buddhasothorn Asthma Severity Score (BASS): A practical screening tool for predicting severe asthma exacerbations for pediatric patients},
journal = {Allergologia et Immunopathologia},
year = {2023},
doi = {10.15586/aei.v51i2.690}
}
EUVIMED